Search The Medical Knowledge Base
Medical News by Category
Diabetes Type 2 News
- Alogliptin (Takeda) filed at EMA for Type 2 Diabetes
Published: Thursday 24 May 2012
- Dulaglutide(Eli Lilly) positive for hypertension effects
Published: Wednesday 23 May 2012
- Study shows Avandamet (Glaxo Smith Kline) superior to metformin alone for Type 2 Diabetes
Published: Wednesday 02 May 2012
- FDA responds to Takeda's NDAs for Type 2 Diabetes therapies Nesina and combination Nesina and Actos
Published: Friday 27 April 2012
- CHMP recommends Forxiga
(AstraZeneca/BMS) for Type 2 Diabetes
Published: Friday 20 April 2012
- FDA updates Victoza (Novo Nordisk) label to show superiority to Januvia
Published: Sunday 08 April 2012
- GSK announces progress in HARMONY Syncria programme for Type 2 Diabetes
Published: Thursday 05 April 2012
- Byetta (Amylin) is EU approved for use with basal insulin in Type 2 Diabetes patients
Published: Saturday 24 March 2012
- Onglyza (BMS/AstraZeneca)alerts for hypersensitivity reactions
Published: Thursday 22 March 2012
- Phase II study of TAK 875 (Takeda) shows improved glycemic control in patients with Type 2 Diabetes
Published: Monday 27 February 2012
- FDA approves Jentadueta(Boehringer/Eli Lilly) for Type 2 Diabetes
Published: Tuesday 31 January 2012
- FDA issues Complete Response Letter for dapagliflozin (AstraZeneca/BMS) for Type 2 Diabetes
Published: Thursday 19 January 2012
- GLP-1R Agonists lead to weight loss in overweight or obese patients
Published: Friday 13 January 2012
- Tradjenta (Boehringer) shows no added benefit in assessment for Type 2 Diabetes
Published: Wednesday 11 January 2012
- Lyxumia(Sanofi-Aventis) positive in
GET-GOAL DUO study in Type 2 Diabetes
Published: Wednesday 07 December 2011
- Onglyza (BMS/AstraZeneca) plus Insulin is EMA approved for Type 2 Diabetes
Published: Tuesday 29 November 2011
- Komboglyze (BMS/AstraZeneca) is EU approved as a combination for Type 2 Diabetes
Published: Tuesday 29 November 2011
- Takeda re-files Nesina at the FDA for Type 2 Diabetes
Published: Friday 25 November 2011
- FDA delays review of Nesina (Takeda) for Type 2 Diabetes treatment
Published: Sunday 20 November 2011
- Potential role for dapagliflozin (BMS/AstraZeneca)in Cardioprotection
Published: Saturday 19 November 2011
- Syncria (*GSK) is inferior to Victoza in Type 2 Diabetes trial
Published: Friday 18 November 2011
- Janacti (Merck Inc.) withdrawn in Europe for Type 2 Diabetes
Published: Friday 18 November 2011
- Amylin acquires world rights to Byetta and Bydureon for Type 2 Diabetes from Eli Lilly
Published: Thursday 10 November 2011
- Byetta (Amylin and Eli Lilly) for Type 2 Diabetes also has rapid and powerful anti-inflammatory action
Published: Saturday 05 November 2011
- Lyxumia (Sanofi-Aventis) is filed at EMA for Type 2 Diabetes
Published: Friday 04 November 2011
- Byetta is FDA approved for use with Insulin Glargine in Type 2 Diabetes
Published: Friday 21 October 2011
- FDA approves Kombiglyze XR for Type 2 diabetes
Published: Sunday 25 September 2011
- CHMP recommends Komboglyze combination for Type 2 Diabetes
Published: Sunday 25 September 2011
- Tradjenta shows long term benefits for Type 2 Diabetes patients
Published: Thursday 22 September 2011
- Galvus achieves significant improvements in Type 2 Diabetes study
Published: Monday 19 September 2011
- Tradjenta shows long term benefits for Type 2 Diabetes patients
Published: Monday 19 September 2011
- Bydureon reduces cardiovascular risk factors in Type 2 Diabetes patients
Published: Saturday 17 September 2011
- TAK 875 a new treatment for Type 2 Diabetes enters Phase III
Published: Saturday 17 September 2011
- Tradjenta launch for Type 2 Diabetes delayed in Germany
Published: Friday 16 September 2011